More details
Hide details
Otorhinolaryngology Department, Sismanogleio General Hospital of Attiki, Greece
Otorhinolaryngology Department, Agia Sofia Children's General Hospital, Athens, Greece
A - Research concept and design; B - Collection and/or assembly of data; C - Data analysis and interpretation; D - Writing the article; E - Critical revision of the article; F - Final approval of article;
Submission date: 2023-04-09
Final revision date: 2023-11-16
Acceptance date: 2023-11-28
Online publication date: 2023-12-22
Publication date: 2023-12-22
Corresponding author
Zacharias Kalentakis   

Otorhinolaryngology Department, Sismanogleio General Hospital of Attiki, Greece, Sismanogleiou, 15126, Athens, Greece
J Hear Sci 2023;13(4):55-59
Genetic deficits cause 80% of congenital prelingual hearing loss. Some 80% of these cases are nonsyndromic and most follow an autosomal recessive pattern of inheritance. More than 80 genes have so far been identified as pathogenic. In this study, we focus on a recently mapped gene, LOXHD1, whose mutated form causes DFNB77 hearing loss, and find a new variant.

Case report:
This is a case study of a 7-year-old male who was admitted to our audiology department with progressive hearing impairment. Pure tone audiometry showed bilateral symmetric hearing impairment, especially at mid to high frequencies. Acoustic immittance tests were normal, but transient evoked otoacoustic emissions and auditory brainstem responses were abnormal for both ears. After physical, clinical, and imaging evaluations, the patient and his parents were genetically tested. Genetic screening showed LOXHD1 hearing loss with a novel combination of alleles, the first such case diagnosed in Greece. The patient now has hearing aids and is being regularly monitored.

Autosomal recessive nonsyndromic hearing loss (ARNSHL), including DFNB77, is the most common sensory deficit in children. Our work describes the first LOXHD1 hearing loss case diagnosed in Greece and adds a novel pathogenic variant to the list of pathogenic LOXHD1 gene variants.

Lieu JEC, Kenna M, Anne S, Davidson L. Hearing loss in children: a review. JAMA, 2020; 324(21): 2195–205.
Morton CC, Nance WE. Newborn hearing screening: a silent revolution. N Engl J Med, 2006; 354(20): 2151–64.
Friedman TB, Griffith AJ. Human nonsyndromic sensorineural deafness. Annu Rev Genomics Hum Genet, 2003; 4: 341–402.
Shearer AE, Hildebrand MS, Schaefer AM, Smith RJH. Genetic hearing loss overview. GeneReviews, 1999. Available from:
Van Laer L, Cryns K, Smith RJ, Van Camp G. Nonsyndromic hearing loss. Ear Hear, 2003; 24(4): 275–88.
Kraaijenga VJC, Derksen TC, Stegeman I, Smit AL. The effect of side of implantation on unilateral cochlear implant performance in patients with prelingual and postlingual sensorineural hearing loss: a systematic review. Clin Otolaryngol, 2018; 43(2): 440–9.
Atik T, Bademci G, Diaz-Horta O, Blanton SH, Tekin M. Whole-exome sequencing and its impact in hereditary hearing loss. Genet Res (Camb), 2015; 97: e4.
Guilford P, Ben Arab S, Blanchard S, Levilliers J, Weissenbach J, Belkahia A, Petit C. A non-syndrome form of neurosensory, recessive deafness maps to the pericentromeric region of chromosome 13q. Nat Genet, 1994; 6(1), 24–8.
Popov TM, Stancheva I, Kachakova DL, Rangachev J, Konov D, Varbanova S, Mitev VI, Kaneva RP, Popova DP. Auditory outcome after cochlear implantation in patients with congenital nonsyndromic hearing loss: influence of the GJB2 status. Otol Neurotol, 2014; 35(8): 1361–5.
Yu S, Chen WX, Zhang YF, Chen Ch, Ni Y, Duan B, Wang H, et al. Recessive LOXHD1 variants cause a prelingual down-sloping hearing loss: genotype–phenotype correlation and three additional children with novel variants. Int J Pediatr Otorhinolaryngol, 2021; 145: 110715.
Naylor CE, Eaton JT, Howells A, Justin N, Moss DS, Titball RW, Basak AK. Structure of the key toxin in gas gangrene. Nat Struct Biol, 1998; 5: 738–46.
Aleem AM, Jankun J, Dignam JD, Walther M, Kuhn H, Svergun DI, Skrzypczak-Jankun E. Human platelet 12-lipoxygenase, new findings about its activity, membrane binding and low-resolution structure. J Mol Biol, 2008; 376: 193–209.
Bateman A, Sandford R. The PLAT domain: a new piece in the PKD1 puzzle. Curr Biol, 1999; CB, 9(16): R588–R590.
Grillet N, Schwander M, Hildebrand MS, Sczaniecka A, Kolatkar A, Velasco J, et al. Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans. Am J Hum Genet, 2009; 85(3): 328–37.
Trouillet A, Miller KK, George SS, Wang P, Noor-E-Seher A, Ricci A, et al. Loxhd1 mutations cause mechanotransduction defects in cochlear hair cells. J Neurosci, 2021; 41(15): 3331–43.
Eppsteiner RW, Shearer AE, Hildebrand MS, Deluca AP, Ji H, Dunn CC, et al. Prediction of cochlear implant performance by genetic mutation: the spiral ganglion hypothesis. Hear Res, 2012; 292: 1–2: 51–8.
Hu S, Sun F, Zhang J, Tang Y, Qiu J, Wang Z, Zhang L. Genetic etiology study of ten Chinese families with nonsyndromic hearing loss. Neural Plast, 2018; 2018: 4920980.
Wesdorp M, Schreur V, Beynon AJ, Oostrik J, van de Kamp JM, Elting MW, et al. Further audiovestibular characterization of DFNB77, caused by deleterious variants in LOXHD1, and investigation into the involvement of Fuchs corneal dystrophy. Clin Genet, 2018; 94: 221–31.
Diaz-Horta O, Duman D, Foster J, Sirmaci A, Gonzalez M, Mahdieh N, et al. Whole-exome sequencing efficiently detects rare mutations in autosomal recessive nonsyndromic hearing loss. PLoS One, 2012; 7(11): e50628.
Lebeko K, Sloan-Heggen CM, Noubiap JJ, Dandara C, Kolbe DL, Ephraim SS, et al. Targeted genomic enrichment and massively parallel sequencing identifies novel nonsyndromic hearing impairment pathogenic variants in Cameroonian families. Clin Genet, 2016; 90(3): 288–90.
Schwander M, Sczaniecka A, Grillet N, Bailey JS, Avenarius M, Najmabadi H, et al. A forward genetics screen in mice identifies recessive deafness traits and reveals that pejvakin is essential for outer hair cell function. J Neurosci, 2007; 27(9): 2163–75.
Mori K, Moteki H, Kobayashi Y, Azaiez H, Booth KT, Nishio S-Y, et al. Mutations in LOXHD1 gene cause various types and severities of hearing loss. Ann Otol Rhinol Laryngol, 2015; 124(1): 135S–41S.
Azaiez H, Booth KT, Ephraim SS, Crone B, Black-Ziegelbein EA, Marini RJ, et al. Genomic landscape and mutational signatures of deafness-associated genes. Am J Hum Genet, 2018; 103: 484–97.
Sloan-Heggen CM, Bierer AO, Shearer AE, Kolbe DL, Nishimura CJ, Frees KL, et al. Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss. Hum Genet, 2016; 135(4): 441–50.
Riazuddin SA, Parker DS, McGlumphy EJ, Oh EC, Iliff BW, Schmedt T, et al. Mutations in LOXHD1, a recessive-deafness locus, cause dominant late-onset Fuchs corneal dystrophy. Am J Hum Gen, 2012; 90(3): 533–9.
Stehouwer M, Bijlsma WR, Van der Lelij A. Hearing disability in patients with Fuchs’ endothelial corneal dystrophy: unrecognized co-pathology? Clin Ophthalmol, 2011; 5: 1297–301.
Vithana EN, Morgan PE, Ramprasad V, Tan DT, Yong VH, Venkataraman D, et al. SLC4A11 mutations in Fuchs endothelial corneal dystrophy. Hum Mol Genet, 2008; 17(5): 656–66.
Riazuddin SA, Vithana EN, Seet LF, Liu Y, Al-Saif A, Koh LW, et al. Missense mutations in the sodium borate cotransporter SLC4A11 cause late-onset Fuchs corneal dystrophy. Hum Mutat, 2010; 31(11): 1261–68.
Journals System - logo
Scroll to top